Navigating the Genetic Frontier for the Integration of Genetic Services into African Healthcare Systems: A scoping review.
Africa
Challenges
Community Engagement
Genetic Services
Healthcare
Opportunities
Journal
Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035
Informations de publication
Date de publication:
28 Feb 2024
28 Feb 2024
Historique:
pubmed:
11
3
2024
medline:
11
3
2024
entrez:
11
3
2024
Statut:
epublish
Résumé
The integration of genetic services into African healthcare systems is a multifaceted endeavor marked by both obstacles and prospects. This study aims to furnish evidence-based recommendations for policymakers and healthcare entities to facilitate the effective assimilation of genetic services within African healthcare systems. Employing a scoping review methodology, we scrutinized peer-reviewed studies spanning from 2003 to 2023, sourced from PubMed, Scopus, and Africa-wide databases. Our analysis drew upon eight pertinent research studies conducted between 2016 and 2023, encompassing diverse genetic topics across six African nations, namely Cameroon, Kenya, Nigeria, Rwanda, South Africa, and Tanzania. The reviewed studies underscored numerous challenges hindering the implementation of genetic services in African healthcare systems. These obstacles encompassed deficiencies in disease awareness and education, impediments to genetic testing, resource scarcities, ethical quandaries, and issues related to follow-up and retention. Nevertheless, the authors also identified opportunities and strategies conducive to successful integration, emphasizing proactive measures such as community engagement, advocacy, and the fostering of supportive networks. The integration of genetic services in Africa holds promise for enhancing healthcare outcomes but also poses challenges and opportunities for healthcare and biotechnology enterprises. To address gaps in disease awareness, we advocate for healthcare providers to invest in educational initiatives, forge partnerships with local institutions, and leverage digital platforms. Furthermore, we urge businesses to innovate and devise cost-effective genetic testing models while establishing online forums to promote dialogue and contribute positively to African healthcare.
Sections du résumé
Background
UNASSIGNED
The integration of genetic services into African healthcare systems is a multifaceted endeavor marked by both obstacles and prospects. This study aims to furnish evidence-based recommendations for policymakers and healthcare entities to facilitate the effective assimilation of genetic services within African healthcare systems.
Methods
UNASSIGNED
Employing a scoping review methodology, we scrutinized peer-reviewed studies spanning from 2003 to 2023, sourced from PubMed, Scopus, and Africa-wide databases. Our analysis drew upon eight pertinent research studies conducted between 2016 and 2023, encompassing diverse genetic topics across six African nations, namely Cameroon, Kenya, Nigeria, Rwanda, South Africa, and Tanzania.
Results
UNASSIGNED
The reviewed studies underscored numerous challenges hindering the implementation of genetic services in African healthcare systems. These obstacles encompassed deficiencies in disease awareness and education, impediments to genetic testing, resource scarcities, ethical quandaries, and issues related to follow-up and retention. Nevertheless, the authors also identified opportunities and strategies conducive to successful integration, emphasizing proactive measures such as community engagement, advocacy, and the fostering of supportive networks.
Conclusion
UNASSIGNED
The integration of genetic services in Africa holds promise for enhancing healthcare outcomes but also poses challenges and opportunities for healthcare and biotechnology enterprises. To address gaps in disease awareness, we advocate for healthcare providers to invest in educational initiatives, forge partnerships with local institutions, and leverage digital platforms. Furthermore, we urge businesses to innovate and devise cost-effective genetic testing models while establishing online forums to promote dialogue and contribute positively to African healthcare.
Identifiants
pubmed: 38464219
doi: 10.21203/rs.3.rs-3978686/v1
pmc: PMC10925396
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NHGRI NIH HHS
ID : U01 HG008226
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG009790
Pays : United States
Organisme : NHLBI NIH HHS
ID : U24 HL135600
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG009716
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007459
Pays : United States
Déclaration de conflit d'intérêts
Competing interests The authors declare that they have no competing interests.
Références
Nat Rev Drug Discov. 2019 Jun;18(6):463-477
pubmed: 30976107
Public Health Genomics. 2012;15(1):34-45
pubmed: 21734357
Am J Med Genet C Semin Med Genet. 2021 Mar;187(1):95-99
pubmed: 33415801
J Clin Epidemiol. 2023 Jul;159:214-224
pubmed: 37286149
Hum Mol Genet. 2021 Oct 1;30(20):R164-R173
pubmed: 34240178
Front Cell Dev Biol. 2017 Sep 21;5:83
pubmed: 28983483
Front Pediatr. 2022 Sep 09;10:826199
pubmed: 36160767
Front Psychiatry. 2023 Jun 21;14:1040026
pubmed: 37415685
J Community Genet. 2021 Oct;12(4):525-538
pubmed: 34228349
BMJ. 2001 Apr 28;322(7293):1027-30
pubmed: 11325768
Ecancermedicalscience. 2023 Aug 14;17:1588
pubmed: 37799957
BMC Med Genomics. 2016 Jan 05;9:1
pubmed: 26729011
Mov Disord. 2021 Apr;36(4):842-851
pubmed: 33513272
N Engl J Med. 2015 Feb 26;372(9):793-5
pubmed: 25635347
J Marriage Fam. 2021 Oct;83(5):1349-1372
pubmed: 34711997
Am J Med. 2005 May;118 Suppl 5A:27S-34S
pubmed: 15850551
Contemp Clin Trials. 2016 Mar;47:101-8
pubmed: 26747051
Front Rehabil Sci. 2021 Nov 18;2:726761
pubmed: 36188771
J Genet Couns. 1995 Dec;4(4):281-300
pubmed: 11655082
Front Genet. 2023 Sep 19;14:1233338
pubmed: 37795248
Genet Med. 2014 Mar;16(3):238-45
pubmed: 23949572
Oman Med J. 2020 Apr 30;35(2):e122
pubmed: 32411417
Int J Breast Cancer. 2016;2016:4792865
pubmed: 27413551
Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):24-37
pubmed: 29512888
J Pers Med. 2023 Jul 27;13(8):
pubmed: 37623443
J Pediatr Hematol Oncol. 2023 Aug 1;45(6):e716-e722
pubmed: 37494609
Nat Rev Genet. 2003 Jan;4(1):61-8
pubmed: 12509754
Genet Med. 2007 Oct;9(10):665-74
pubmed: 18073579
Genet Med. 2022 May;24(5):1108-1119
pubmed: 35227608
J Genet Couns. 2013 Dec;22(6):762-70
pubmed: 23963834
J Med Virol. 2023 Jan;95(1):e28295
pubmed: 36366938
Eur J Hum Genet. 2008 Apr;16(4):445-52
pubmed: 18197196
Genet Med. 2015 Mar;17(3):169-76
pubmed: 25210938